BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3888440)

  • 1. Comparison between rush immunotherapy with a standardized allergen and an alum adjuved pyridine extracted material in grass pollen allergy.
    Bousquet J; Guerin B; Dotte A; Dhivert H; Djoukhadar F; Hewitt B; Michel FB
    Clin Allergy; 1985 Mar; 15(2):179-93. PubMed ID: 3888440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific IgE response before and after rush immunotherapy with a standardized allergen or allergoid in grass pollen allergy.
    Bousquet J; Braquemond P; Feinberg J; Guerin B; Maasch H; Michel FB
    Ann Allergy; 1986 Jun; 56(6):456-9. PubMed ID: 3717711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rush immunotherapy with sublingual administration of grass allergen extract.
    Feliziani V; Marfisi RM; Parmiani S
    Allergol Immunopathol (Madr); 1993; 21(5):173-8. PubMed ID: 8160561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rush immunotherapy with a standardized Bermuda grass pollen extract.
    Armentia-Medina A; Blanco-Quiros A; Martin-Santos JM; Alvarez-Cuesta E; Moneo-Goiri I; Carreira P; Losada-Cosmes E
    Ann Allergy; 1989 Aug; 63(2):127-35. PubMed ID: 2669567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment IgE sensitization patterns determine the molecular profile of the IgG4 response during updosing of subcutaneous immunotherapy with timothy grass pollen extract.
    Schmid JM; Würtzen PA; Dahl R; Hoffmann HJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):562-70. PubMed ID: 26141262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reduced allergen immunotherapy of grass pollinosis (author's transl)].
    Horak F; Jäger S; Skoda-Türk R
    Wien Klin Wochenschr Suppl; 1980; 117():36-8. PubMed ID: 6936982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the clinical and immunological effects of an alum-precipitated five-grass extract with a conjugated two-grass extract in the desensitization of hay fever.
    Dorward AJ; Waclawski E; Kerr JW
    Clin Allergy; 1984 Nov; 14(6):561-70. PubMed ID: 6391736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and immunological response to oral and subcutaneous immunotherapy with grass pollen extracts. A prospective study.
    Rebien W; Puttonen E; Maasch HJ; Stix E; Wahn U
    Eur J Pediatr; 1982 Jul; 138(4):341-4. PubMed ID: 7128644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Allergen immunotherapy with an immunochemically characterized grass pollen extract: change in follow-up sensitization parameters].
    Collet M; Urbanek R
    Klin Padiatr; 1989; 201(3):183-8. PubMed ID: 2739344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study.
    Ott H; Sieber J; Brehler R; Fölster-Holst R; Kapp A; Klimek L; Pfaar O; Merk H
    Allergy; 2009 Sep; 64(9):1394-401. PubMed ID: 19764942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts.
    Bousquet J; Becker WM; Hejjaoui A; Chanal I; Lebel B; Dhivert H; Michel FB
    J Allergy Clin Immunol; 1991 Jul; 88(1):43-53. PubMed ID: 2071784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy.
    Aasbjerg K; Backer V; Lund G; Holm J; Nielsen NC; Holse M; Wagtmann VR; Würtzen PA
    Clin Exp Allergy; 2014 Mar; 44(3):417-28. PubMed ID: 24734285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accelerated Up-Dosing of Subcutaneous Immunotherapy with a Registered Allergoid Birch Pollen Preparation.
    Buczyłko K; van der Werf JF; Boot D; van Ree R
    Int Arch Allergy Immunol; 2017; 172(3):183-186. PubMed ID: 28380494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy.
    Panzner P; Petráš M; Sýkora T; Lesná IK; Liška M
    Allergy Asthma Proc; 2011; 32(2):142-50. PubMed ID: 21439167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.